# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054604
Filing Date
2024-05-07
Accepted
2024-05-07 16:30:43
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | adpt-20240331.htm iXBRL | 10-Q | 1965594
2 | EX-31.1 | adpt-ex31_1.htm | EX-31.1 | 16771
3 | EX-31.2 | adpt-ex31_2.htm | EX-31.2 | 16765
4 | EX-32.1 | adpt-ex32_1.htm | EX-32.1 | 10145
5 | EX-32.2 | adpt-ex32_2.htm | EX-32.2 | 11316
| Complete submission text file | 0000950170-24-054604.txt |  | 8296555

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | adpt-20240331.xsd | EX-101.SCH | 1137204
77 | EXTRACTED XBRL INSTANCE DOCUMENT | adpt-20240331_htm.xml | XML | 1520251

Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 24922500
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)